Profound Medical PROF US — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Profound Medical in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Profound Medical's us — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Profound Medical's US — revenue?
- Profound Medical (PROF) reported US — revenue of $1.62M in Q1 2026.
- How has Profound Medical's US — revenue changed year-over-year?
- Profound Medical's US — revenue increased by 4.7% year-over-year, from $1.54M to $1.62M.
- What is the long-term trend for Profound Medical's US — revenue?
- Over 2 years (2023 to 2025), Profound Medical's US — revenue has grown at a 54.6% compound annual growth rate (CAGR), from $5.13M to $12.25M.
- What does US — revenue mean?
- Represents the total gross income generated from the sale of medical devices and related services within the United States market. This metric serves as a primary indicator of market penetration and commercial adoption of the company's therapeutic systems in the region.